COVID-19 Rebound After Paxlovid Treatment: A Case Series and Review of Literature

被引：19

作者：

Alshanqeeti, Shatha ^{[1
,2
]}

Bhargava, Ashish ^{[1
]}

机构：

[1] Ascension St John Hosp, Internal Med, Detroit, MI 48236 USA

[2] King Saud Univ, Infect Dis, Riyadh, Saudi Arabia

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2022年 / 14卷 / 06期

关键词：

covid-19; protease inhibitor; paxlovid; nirmatrelvir; ritonavir;

D O I：

10.7759/cureus.26239

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Since the declaration of COVID-19 as a pandemic in 2020, several therapies have been developed to reduce symptoms of COVID-19 infection and prevent progression. Paxlovid is an antiviral that was authorized for emergency use in December 2021 for non-hospitalized symptomatic patients with COVID-19 to prevent progression to severe disease. Relapse of symptoms following a period of improvement after treatment with Paxlovid has been described recently. Data are limited, but the disease course in available case reports is usually mild and requires no additional antiviral treatment. We present the cases of COVID-19 relapse (COVID-19 rebound) in two patients following treatment with Paxlovid.

引用

页数：6

共 9 条

[1]

[Anonymous], 2022, HAN ARCH 00467 COVID

[2] COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021 [J].

Birhane, Meseret ;

Bressler, Sara ;

Chang, Gregory ;

Clark, Thomas ;

Dorough, Layne ;

Fischer, Marc ;

Watkins, Louise Francois ;

Goldstein, Jason M. ;

Kugeler, Kiersten ;

Langley, Gayle ;

Lecy, Kristin ;

Martin, Stacey ;

Medalla, Felicita ;

Mitruka, Kiren ;

Nolen, Leisha ;

Sadigh, Katrin ;

Spratling, Robin ;

Thompson, Gail ;

Trujillo, Alma .

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (21) :792-793

[3]

CDC, 2020, UND MED COND ASS HIG

[4]

Charness M, 2022, PREPRINT, DOI DOI 10.21203/RS.3.RS-1588371/V1

[5]

FDA, 2021, News release

[6] Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 [J].

Hammond, Jennifer ;

Leister-Tebbe, Heidi ;

Gardner, Annie ;

Abreu, Paula ;

Bao, Weihang ;

Wisemandle, Wayne ;

Baniecki, MaryLynn ;

Hendrick, Victoria M. ;

Damle, Bharat ;

Simon-Campos, Abraham ;

Pypstra, Rienk ;

Rusnak, James M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (15) :1397-1408

[7] ORIGINAL RESEARCH Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020-March 2021 [J].

Kompaniyets, Lyudmyla ;

Pennington, Audrey F. ;

Goodman, Alyson B. ;

Rosenblum, Hannah G. ;

Belay, Brook ;

Ko, Jean Y. ;

Chevinsky, Jennifer R. ;

Schieber, Lyna Z. ;

Summers, April D. ;

Lavery, Amy M. ;

Preston, Leigh Ellyn ;

Danielson, Melissa L. ;

Cui, Zhaohui ;

Namulanda, Gonza ;

Yusuf, Hussain ;

Mac Kenzie, William R. ;

Wong, Karen K. ;

Baggs, James ;

Boehmer, Tegan K. ;

Gundlapalli, Adi V. .

PREVENTING CHRONIC DISEASE, 2021, 18

[8] Antiviral Drug Discovery for the Treatment of COVID-19 Infections [J].

Ng, Teresa, I ;

Correia, Ivan ;

Seagal, Jane ;

DeGoey, David A. ;

Schrimpf, Michael R. ;

Hardee, David J. ;

Noey, Elizabeth L. ;

Kati, Warren M. .

VIRUSES-BASEL, 2022, 14 (05)

[9]

nih, 2022, RIT BOOST NIRM PAXL

← 1 →